Current:Home > ContactFDA advisers back updated COVID shots for fall vaccinations -ValueCore
FDA advisers back updated COVID shots for fall vaccinations
View
Date:2025-04-13 06:30:41
A panel of expert advisers to the Food and Drug Administration voted unanimously Thursday to recommend that the COVID-19 vaccine be updated to target emerging subvariants of omicron.
The COVID shot that's currently available is known as a "bivalent" vaccine because it was tailored to target both the original strain of the coronavirus and the omicron subvariants that dominated last winter.
But the FDA panel recommended that drugmakers abandon the bivalent design and instead move to a "monovalent" vaccine that only targets omicron subvariants. The idea is to roll out the newly formulated shots in anticipation of a possible uptick in cases this fall.
The committee specifically supported targeting the subvariant XBB.1.5, which accounts for about 40% of new infections in the U.S.
In an analysis, FDA scientists said data from vaccine manufacturers indicate that an updated monovalent formulation that targets XBB subvariants "elicits stronger neutralizing antibody responses" against XBB strains than current bivalent vaccines.
"There doesn't seem to be any particular advantage to a bivalent vaccine," said Dr. Eric Rubin, a professor of immunology and infectious diseases at Harvard who is also a member of the advisory committee.
While there was wide agreement about moving to a monovalent vaccine, there was considerable debate among committee members over whether the COVID-19 vaccine should be handled like the influenza vaccine, which is revamped every year in anticipation of flu season.
"People understand a yearly influenza vaccine," said Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research. "At this point it may not be yearly, but, for all intents and purposes, it looks like by next fall there will be further drift from this [strain] and we may have to come back here."
But some worried that drawing too close a parallel to influezna could actually lead to confusion among Americans.
"This is not the flu," said committee member Dr. Paul Offit, a professor of pediatrics at the Children's Hospital of Philadelphia. He pointed out that many Americans already have some protection against severe illness from COVID-19 because of prior infection, vaccination, or both.
"I'm all for updating this vaccine, but I think we need to define... who really benefits from booster dosing? Because it's not everybody," he said.
It's not yet clear who federal officials will recommend should get the updated omicron vaccine.
During the meeting, the CDC shared data that shows that, since last April, COVID hospitalizations and deaths have been low in most groups. But they have been disproportionately high in people who are 75 or older, suggesting this group might need extra protection. Those with health issues like chronic lung disease or diabetes might also have higher risks.
The FDA is now going to consider the committee's discussion and will likely issue an official recommendation about the vaccine formulation within a few days, which will give vaccine makers a path to follow.
If all goes according to plan, it's expected the new vaccines should be out in the fall – by around late September or early October.
veryGood! (824)
Related
- Meet the volunteers risking their lives to deliver Christmas gifts to children in Haiti
- Chicago police search for a 16-year-old boy who vanished from O'Hare International Airport
- Michigan State to cancel classes on anniversary of mass shooting
- Special counsel Jack Smith announces new Trump charges, calling Jan. 6 an unprecedented assault
- Google unveils a quantum chip. Could it help unlock the universe's deepest secrets?
- Driver accused of gross negligence in crash that killed actor Treat Williams
- Republican National Committee boosts polling and fundraising thresholds to qualify for 2nd debate
- Lori Vallow Daybell, convicted on murder charges in Idaho, still faces charges in Arizona
- Tarte Shape Tape Concealer Sells Once Every 4 Seconds: Get 50% Off Before It's Gone
- Strike avoided: UPS Teamsters come to tentative agreement, voting to start this week
Ranking
- NHL in ASL returns, delivering American Sign Language analysis for Deaf community at Winter Classic
- Employee put on leave after diesel fuel leaks into city's water supply
- Taylor Swift Gives $55 Million in Bonuses to Her Eras Tour Crew
- Extreme heat costs the U.S. $100 billion a year, researchers say
- Spooky or not? Some Choa Chu Kang residents say community garden resembles cemetery
- Michigan Supreme Court suspends judge accused of covering up her son’s abuse of her grandsons
- Overstock.com is revamping using Bed Bath & Beyond's name
- Police search for teen in fatal stabbing of NYC dancer
Recommendation
Civic engagement nonprofits say democracy needs support in between big elections. Do funders agree?
10 injured after stolen vehicle strikes pedestrians in New York City, police say
India's Haryana state on edge as authorities block internet, deploy troops amid deadly sectarian violence
Stock market today: Asian shares slip, echoing Wall Street’s retreat from its rally
'Kraven the Hunter' spoilers! Let's dig into that twisty ending, supervillain reveal
24-year-old NFL wide receiver KJ Hamler reveals he has a heart condition, says he's taking a quick break
How You Can Stay in Gwyneth Paltrow’s Montecito Guest House
James Larkin, Arizona executive who faced charges of aiding prostitution, dead at 74